Dermatology CE & Educational Resources
As the body’s largest organ, the skin is constantly working to protect the body’s internal organs and regulate temperature, among other vital functions, and the condition of a person’s skin can reflect their overall health and aging status. Diseases of the skin, such as atopic dermatitis and psoriasis, affect people of all ages and can take a major toll on the patient’s quality of life. CME Outfitters has developed this Dermatology Education Hub with a number of educational activities and resources to help you better treat and manage your patients with aging skin or skin disease in order to increase quality of life.
Our activities offer many credit types, including CME, AAFP Prescribed Credit, CNE, CPE, ABIM MOC, and ABP MOC. Each activity has been designed to meet the requirements for CME for MIPS. See each activity’s information page for the exact credit type and amount of credit offered.
Accurate Diagnosis, Evidence-Based Treatment, and Long-Term Management in Persons of Color with AD
|
In this CME Outfitters Live and OnDemand, expert faculty will discuss the influence of structural racism on disparities in the diagnosis and treatment of AD in African American children, recommended screening for AD among pediatric patients of color, and strategies for managing pediatric patients with AD during the COVID-19 pandemic. |
Signals of Change in the Management of Atopic Dermatitis
|
Atopic dermatitis (AD) is a chronic, inflammatory skin disease that effects up to 18% of children and up to 10% of adults and can have a substantial negative impact on the quality of life (QoL) of patients and their families. Its management is challenging at any age, with patients and caregivers often becoming overwhelmed by the chronic and relapsing nature of AD. Establishing disease severity is essential to inform treatment decisions, as is information on new clinical trial data for therapies such as oral Janus kinase (JAK) inhibitors. Thus, education that provides tools to establish disease severity and information on the development of new agents is warranted in order to mitigate the clinical and QoL impact of AD. |
The Patient Voice: Defining Health Care Disparities in Atopic Dermatitis Care
|
This CME Outfitters Live and OnDemand will feature patient voices in addition to expert faculty discussing the implementation of best practices for diagnosing, evaluating, and treating AD among patients of color, the latest evidence on health care disparities in patients with AD and the impact of COVID-19 on the care of patients of color with AD, as well as the application of optimal strategies to manage patients with AD during the COVID-19 pandemic. |
All Hands: Integrating a Team Approach to Risk-Benefit Individualization of Rheumatoid Arthritis and Psoriatic Arthritis Therapy
|
Although rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are associated with irreversible joint damage and physical disability, remission is now an achievable goal for the majority of patients, owing to advances in early diagnosis, new therapies, and improved treatment strategies. This CME Outfitters OnDemand webcast focuses on integrating a multidisciplinary approach to treating PsA and RA through case-based learning, with expert faculty discussing management strategies and how to integrate shared decision-making (SDM) into practice to facilitate appropriate treatment selection and empower patients. |
Hitting the Target with IL-23 Inhibitors in Psoriatic Arthritis
|
Psoriatic arthritis (PsA) is a chronic, inflammatory, musculoskeletal disease with a significant impact on quality of life and functional ability. Despite the data showing the overall impact of PsA, delays in diagnosis are common, which can lead to long-term joint damage and functional disability. In this CME Outfitters OnDemand activity, expert faculty will focus on assessment, treatment, and management strategies to provide patients with the best treatment aligned with evolving evidence and expert recommendations. |
Why New Treatments are Needed for the Management of Psoriasis
|
This CME Outfitters Snack will evaluate the factors that are associated with patient perspectives on disease burden, address that burden, and the unmet treatment needs in the management of PsO, in order to show why new treatments are needed. |
Refining Treatment Targets for the Management of Psoriasis
|
In this CME Outfitters Snack, expert faculty evaluate the role of TYK2 versus JAK1, JAK2, and JAK3 signaling pathways in PsO as the differences in mechanisms of action offer new and effective options for patients with PsO. |
Forecasting a Bright and Clear Tomorrow for Psoriasis Treatment
|
This CME Outfitters Snack will focus on evaluating the efficacy and safety data for these emerging therapies, and on engaging patients in discussion about their treatment goals to improve treatment choices. |
Pathogenesis of Psoriatic Arthritis: A Broader Understanding to Inform Next Steps
|
The first episode of this CME Outfitters Snack series on the evolving treatment landscape for PsA features expert faculty describing clinically relevant pathophysiologic processes that contribute to the development of psoriatic arthritis in order to facilitate proper screening and faster diagnosis of patients with PsA. |
Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation
|
This CME Outfitters Snack focuses on evaluating the mechanistic rationale for novel and emerging treatments for PsA as well as assessing safety and efficacy data for current and emerging JAK inhibitors to determine their role in the management of PsA in order to help narrow the treatment gap. |
Joining Forces in the Coordination of Care of Patients with Psoriatic Arthritis
|
The final installment of this CME Outfitters Snack series on managing PsA features discussion on the incorporation of patient-reported outcomes into shared decision-making, employing a multidisciplinary approach to coordination of care, and how best to monitor patients with PsO for PsA at each visit. |
Immune Pathways in Systemic Lupus Erythematosus (SLE)
|
The first episode of this CMEOCast podcast series on systemic lupus erythematosus (SLE) focuses on the heterogeneity of lupus, including the multiple immune pathways that are active in it and how knowledge of immunopathogenesis has informed drug development. |
Safety and Efficacy of Emerging Treatments in the Management of Systemic Lupus Erythematosus (SLE)
|
However, the future is bright for patients with lupus, as drug development activities are currently unprecedented. In this CMEOCast podcast episode, expert faculty evaluate the safety and efficacy of these emerging therapies. |
Improving the Application of Shared Decision-Making in the Selection of SLE Treatments
|
The final episode in this CMEOCast podcast series on SLE addresses the impact and burden of SLE on quality of life, the integration of PROs when caring for patients with SLE, and the implementation of best practices for SDM in order to engage patients as partners in their care. |
Eliminating Diagnostic Delays in Psoriatic Arthritis
|
The first episode of this CMEOCast podcast series on PsA focuses on recognizing and reducing the impact of delays to diagnosis as well as seizing opportunities to screen patients with PsO for PsA to facilitate a prompt referral and initiation of treatment to optimize outcomes. |
Adding Tools to the Toolbox: New and Emerging Treatments for Psoriatic Arthritis
|
In this CMEOCast podcast, expert faculty will present key clinical efficacy and safety data for novel and emerging agents and discuss how best to apply this data to treatment decisions in patients with PsA. |
Comprehensive and Coordinated Patient-Centered Care in Psoriatic Arthritis
|
The final episode of this CMEOCast podcast series on psoriatic arthritis (PsA) focuses on how clinicians can collaborate with each other and with their patients in order to optimize treatment regimens across the health care continuum. |
Improving Outcomes for Patients with Psoriatic Arthritis: Integrating a Comprehensive, Patient-Centered Care Model into Your Practice
|
In this CMEOCast podcast, expert faculty focus on the latest evidence on screening patients for PsA, individualizing treatment that considers patient-reported outcomes (PROs), and using patient-centered approaches for care, with the goal of optimizing patient outcomes. |
Let’s Talk Psoriasis: Best Practice Videos
Atopic Dermatitis Toolkit
Reading Room
- Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape
- Boguniewicz M, Fonacier L, Guttman-Yassky E, Ong PY, Silverberg J, Farrar JR. Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape. Ann Allergy Asthma Immunol.2018;120(1):10-22.e2.
- New and developing therapies for atopic dermatitis
- Hajar T, Hanifin J. New and developing therapies for atopic dermatitis. An Bras Dermatol. 2018;93:104-107.
- Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitis
- Silverberg JI, Gelfand J, Margolis D, et al. Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitis. Ann Allergy Asthma Immunol. 2018;121:464-468.
- Improving value for patients with eczema
- Block J. Improving value for patients with eczema. Value in Health. 2018;21:380-385.
Patient Resources
Educational Outcomes
Education via Medical Simulation Improves Screening and Treatment of Psoriasis
|
CME Outfitters is proud to share our findings from a recent study aimed at determining whether online medical simulation-based education could assist clinicians in achieving best practices related to screening for comorbidities, such as psoriatic arthritis or cardiovascular disorders, as well as counseling and treating for patients with psoriasis. Read the full findings below! |